1105 Usefulness Of The New Indicator Test (Neuropad) As Screening Tool In Identifying Patients With Type Ii Diabetes Mellitus (Dm) At Risk Of Foot Ulceration.

Stavros Bousboulas, Saint Panteleimon Hospital
K. Vasilikos -
A. Galis -
J. Tsakanikas -
M. Christoforidou -
S. Pappas -
Background and Aims: Peripheral Sudomotor Neuropathy (PSN) in combination with Peripheral Sensorimotor Neuropathy (PSMN) are the most important factors for the pathogenesis of diabetic foot ulcers. The indicator test neuropad (Np) measure the dermal foot perspiration (colour change Blue - Pink)
Aim of this study was to evaluate the sensitivity and specificity of Np to identifying patients with DFS, and also the influence of age, diabetes duration DD, BMI, HbA1c of the results.
Materials and Methods:
This study included 130 type II patients DM (64 men), mean age of 65,25±10,86 years, average duration of DM was 15,12±8,19 years. Np was placed at the plantar of the first metatarsal of both feet, and we examine the colour after 10 minutes. Patients were examined for PSMN by using neuropathy disability score NDS as proposed from M.J.Young For statistical analysis of influence of age, DD, BMI, HbA1c used ANOVA.
Results: 65 patients proved to have PSMN (DFS) 50%.
Groups A: Healthy 65, B: Early PSMN 37- 36.
The sensitivity and specificity of Np was 78%, 61% respectively.
The Np sensitivity for group C was 92%
The anova analysis results was positive for PSMN and Np test only for the influence of DD and HbA1c.
Conclusion: The Np test has good sensitivity and moderate specificity for the detection of patients with DFS especially in Group C. This finding along with the simplicity, objectivity of the technique, suggests that Np may be a useful screening tool to in identifying patients with DM and DFS especially in Primary Health Care.
Usefulness of the new indicator test (neuropad) as screening tool in identifying patients with type II diabetes mellitus (DM) at risk of foot ulceration.